Ren M, Liu Y, Lin B, Zou W, Zhu B, Wu J
Front Med (Lausanne). 2025; 12:1539652.
PMID: 40041461
PMC: 11876163.
DOI: 10.3389/fmed.2025.1539652.
Josse M, Patrier L, Cristol J, Isnard M, Grandperrin A, Turc-Baron C
Clin Kidney J. 2025; 18(1):sfae352.
PMID: 40008351
PMC: 11852286.
DOI: 10.1093/ckj/sfae352.
Duni A, Kitsos A, Bechlioulis A, Lakkas L, Markopoulos G, Tatsis V
Int J Mol Sci. 2024; 25(17).
PMID: 39273110
PMC: 11395156.
DOI: 10.3390/ijms25179162.
Lima Posada I, Soulie M, Stephan Y, Palacios Ramirez R, Bonnard B, Nicol L
J Am Heart Assoc. 2024; 13(12):e032971.
PMID: 38842271
PMC: 11255738.
DOI: 10.1161/JAHA.123.032971.
Dobre M, Ahlawat S, Schelling J
Curr Opin Nephrol Hypertens. 2024; 33(2):203-211.
PMID: 38193308
PMC: 10872957.
DOI: 10.1097/MNH.0000000000000952.
Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease.
Ogata H, Sugawara H, Yamamoto M, Ito H
J Atheroscler Thromb. 2023; 31(1):1-14.
PMID: 37766573
PMC: 10776333.
DOI: 10.5551/jat.RV22012.
Extracorporeal organ support and the kidney.
Mucino-Bermejo M
Front Nephrol. 2023; 2:924363.
PMID: 37674997
PMC: 10479766.
DOI: 10.3389/fneph.2022.924363.
Cardiovascular changes in the NZB/W F1 mouse model of lupus nephritis.
Bohme R, Daniel C, Ferrazzi F, Angeloni M, Ekici A, Winkler T
Front Cardiovasc Med. 2023; 10:1182193.
PMID: 37554366
PMC: 10405627.
DOI: 10.3389/fcvm.2023.1182193.
Combinative predictive effect of left ventricular mass index, ratio of HDL and CRP for progression of chronic kidney disease in non-dialysis patient.
Tang L, Li S, Guo X, Lai J, Liu P, Fang J
Int Urol Nephrol. 2023; 56(1):205-215.
PMID: 37204678
DOI: 10.1007/s11255-023-03624-y.
Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy.
Neprasova M, Maixnerova D, Sparding N, Genovese F, Karsdal M, Koprivova H
Int J Mol Sci. 2023; 24(3).
PMID: 36768385
PMC: 9917115.
DOI: 10.3390/ijms24032064.
Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a Review of Cardiorenal Syndrome Type 4.
Minciunescu A, Genovese L, deFilippi C
SN Compr Clin Med. 2022; 5(1):15.
PMID: 36530959
PMC: 9734879.
DOI: 10.1007/s42399-022-01347-2.
Cardiac metabolic remodelling in chronic kidney disease.
Patel N, Yaqoob M, Aksentijevic D
Nat Rev Nephrol. 2022; 18(8):524-537.
PMID: 35637381
DOI: 10.1038/s41581-022-00576-x.
Effect and correlation of patent vascular access flow on left ventricular hypertrophy in kidney transplant patients.
Lukkanalikitkul E, Pussadhamma B, Ahooja A, Ungprasert P, Toparkngam P, Nawapun S
Int J Cardiol Heart Vasc. 2022; 40:101048.
PMID: 35586170
PMC: 9108726.
DOI: 10.1016/j.ijcha.2022.101048.
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
Yanucil C, Kentrup D, Campos I, Czaya B, Heitman K, Westbrook D
Kidney Int. 2022; 102(2):261-279.
PMID: 35513125
PMC: 9329240.
DOI: 10.1016/j.kint.2022.03.028.
Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial.
Charytan D, Hsu J, Mc Causland F, Waikar S, Ikizler T, Raj D
Kidney360. 2022; 1(12):1380-1389.
PMID: 35372900
PMC: 8815530.
DOI: 10.34067/KID.0004342020.
Prognostic Implication of Longitudinal Changes in Cardiothoracic Ratio and Aortic Arch Calcification in Hemodialysis Patients.
Chung T, Liu Y, Huang J, Wu P, Tu H, Chen S
J Pers Med. 2021; 11(8).
PMID: 34442433
PMC: 8397966.
DOI: 10.3390/jpm11080788.
Comorbidities Associated with One-Year Mortality in Patients with Atrial Fibrillation and Heart Failure.
Horodinschi R, Diaconu C
Healthcare (Basel). 2021; 9(7).
PMID: 34356208
PMC: 8303755.
DOI: 10.3390/healthcare9070830.
Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients.
Braunisch M, Gundel P, Werfel S, Mayer C, Bauer A, Haller B
J Nephrol. 2021; 35(1):233-244.
PMID: 34014512
PMC: 8803820.
DOI: 10.1007/s40620-021-01068-0.
Involvement of chronic inflammation via monocyte chemoattractant protein-1 in uraemic cardiomyopathy: a human biopsy study.
Nakano T, Onoue K, Seno A, Ishihara S, Nakada Y, Nakagawa H
ESC Heart Fail. 2021; 8(4):3156-3167.
PMID: 33988313
PMC: 8318461.
DOI: 10.1002/ehf2.13423.
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease.
Ravid J, Kamel M, Chitalia V
Nat Rev Nephrol. 2021; 17(6):402-416.
PMID: 33758363
DOI: 10.1038/s41581-021-00408-4.